” Although the Ricaurte Tale was unfolding, MAPS at last gained FDA indicator-off on a protocol for human trials of copyright to be a treatment for PTSD, but only right after it purchased a $1 million insurance policies policy to indemnify the assessment board.Inside the race to obtain health care licensing for psychedelics, the compound in pole